Shopping Cart
Remove All
Your shopping cart is currently empty
NSC-139021 (ERGi-USU) is a Rio2 kinase (RIOK2) inhibitor that inhibits ERG protein.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | $41 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $45 | In Stock | In Stock |
| Description | NSC-139021 (ERGi-USU) is a Rio2 kinase (RIOK2) inhibitor that inhibits ERG protein. |
| Targets&IC50 | ERG (positive cancer cells):30 to 400 nM (IC50) |
| In vitro | ERGi-USU selectively inhibits growth of ERGpositive cancer cell lines with minimal effect on normal prostate or endothelial cells or ERG-negative tumor cell lines.?The IC50 of ERGi-USU for cell growth inhibition of responsive cell lines range between 30 nM to 400 nM[1]. |
| Molecular Weight | 255.3 |
| Formula | C13H9N3OS |
| Cas No. | 1147-56-4 |
| Smiles | Oc1ccc2ccccc2c1N=Nc1nccs1 |
| Relative Density. | 1.4g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 62 mg/mL (242.85 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.83 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.